amorphous calcium carbonate (AMOR 18) / Amorphical Ltd 
Welcome,         Profile    Billing    Logout  

2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
amorphous calcium carbonate (AMOR 18) / Amorphical Ltd
NCT04900337: Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available Care (BAT), for the Treatment of Moderate to Severe COVID-19 Patients.

Completed
1/2
66
RoW
AMOR 18 Powder & Inhalation, Placebo
Amorphical Ltd.
Covid19
06/23
06/23
AMCS009, NCT06288490: A Single Arm Study Comparing ACC Supplement to CCS in Management of Hypoparathyroidism

Terminated
N/A
10
RoW
amorphous calcium carbonate, ACC
Amorphical Ltd.
Hypoparathyroidism
06/14
06/14

Download Options